MERRIMACK PHARMACEUTICALS, INC. $40,000,000 of shares of Common Stock, par value $0.01 per share Sales AgreementMerrimack Pharmaceuticals Inc • July 13th, 2015 • Pharmaceutical preparations • New York
Company FiledJuly 13th, 2015 Industry JurisdictionMerrimack Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: